Insider · CIK 0001239247

VENROCK MANAGEMENT III LLC

Reports to the SEC for 7 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001239247

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+48.3K sh	—	—	48,333
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+215K sh	—	—	214,820
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+5,367 sh	—	—	5,367
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+227K sh	—	—	275,450
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+1.01M sh	—	—	1,224,234
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+25.2K sh	—	—	30,600
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+9,285 sh	—	—	284,735
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+41.3K sh	—	—	1,265,504
2014-09-29	Vitae Pharmaceuticals, IncC Conversion	10% Owner	CConversion	+1,031 sh	—	—	31,631
2014-09-29	Vitae Pharmaceuticals, IncP Purchase	10% Owner	PPurchase	+139K sh	$8.00	+$1.11M	423,754
2014-09-29	Vitae Pharmaceuticals, IncP Purchase	10% Owner	PPurchase	+618K sh	$8.00	+$4.94M	1,883,372
2014-09-29	Vitae Pharmaceuticals, IncP Purchase	10% Owner	PPurchase	+15.4K sh	$8.00	+$124K	47,077
2014-09-29	Vitae Pharmaceuticals, IncSeries A-2 Preferred StockC Conversion	10% Owner	CConversion	−32.1K sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries A-2 Preferred StockC Conversion	10% Owner	CConversion	−143K sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries A-2 Preferred StockC Conversion	10% Owner	CConversion	−3,563 sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries B Preferred StockC Conversion	10% Owner	CConversion	−227K sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries B Preferred StockC Conversion	10% Owner	CConversion	−1.01M sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries B Preferred StockC Conversion	10% Owner	CConversion	−25.2K sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries C Preferred StockC Conversion	10% Owner	CConversion	−9,285 sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries C Preferred StockC Conversion	10% Owner	CConversion	−41.3K sh	—	—	0
2014-09-29	Vitae Pharmaceuticals, IncSeries C Preferred StockC Conversion	10% Owner	CConversion	−1,031 sh	—	—	0
2005-07-06	SIRNA THERAPEUTICS INCP Purchase	10% Owner	PPurchase	+1M sh	$1.60	+$1.6M	6,038,805
2005-07-06	SIRNA THERAPEUTICS INCWarrants (right to buy)P Purchase	10% Owner	PPurchase	+360K sh	—	—	360,000
2005-06-30	SIRNA THERAPEUTICS INCWarrant (right to buy)J Other	10% Owner	JOther	−950K sh	—	—	0
2005-06-30	SIRNA THERAPEUTICS INCWarrant (right to buy)P Purchase	10% Owner	PPurchase	+950K sh	—	—	950,093
2004-12-30	SIRNA THERAPEUTICS INCX Exercise of In-Money	10% Owner	XExercise of In-Money	+864K sh	$2.52	+$2.18M	5,038,805
2004-12-30	SIRNA THERAPEUTICS INCWarrant (right to buy)J Other	10% Owner	JOther	−864K sh	—	—	0
2004-12-30	SIRNA THERAPEUTICS INCWarrant (right to buy)J Other	10% Owner	JOther	+950K sh	—	—	950,093
2004-12-30	SIRNA THERAPEUTICS INCWarrant (right to buy)J Other	10% Owner	JOther	+864K sh	—	—	863,721
2004-12-30	SIRNA THERAPEUTICS INCWarrant (right to buy)X Exercise of In-Money	10% Owner	XExercise of In-Money	−864K sh	—	—	0
2004-02-10	RENOVIS INCC Conversion	10% Owner	CConversion	+499K sh	—	—	502,881
2004-02-10	RENOVIS INCC Conversion	10% Owner	CConversion	+407K sh	—	—	909,873
2004-02-10	RENOVIS INCC Conversion	10% Owner	CConversion	+533K sh	—	—	1,443,206
2004-02-10	RENOVIS INCSeries B Preferred StockC Conversion	10% Owner	CConversion	−2.25M sh	—	—	0
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	10% Owner	CConversion	−1.83M sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	10% Owner	CConversion	−2.4M sh	—	—	0

Recent filings

Accepted (ET)
Oct 14
Vitae Pharmaceuticals, Inc0001209191-14-060548
SEC(opens sec.gov)

Companies

Address

530 FIFTH AVENUE 22ND FLOOR

NEW YORK, NY, 10036